nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0944	0.164	CbGbCtD
Perphenazine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0658	0.114	CbGbCtD
Perphenazine—CYP2C8—Progesterone—uterine cancer	0.0625	0.108	CbGbCtD
Perphenazine—CYP2C19—Progesterone—uterine cancer	0.0524	0.0909	CbGbCtD
Perphenazine—CYP1A2—Progesterone—uterine cancer	0.0484	0.0839	CbGbCtD
Perphenazine—CYP2C9—Progesterone—uterine cancer	0.0436	0.0756	CbGbCtD
Perphenazine—CYP2D6—Progesterone—uterine cancer	0.0399	0.0691	CbGbCtD
Perphenazine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0383	0.0664	CbGbCtD
Perphenazine—CYP2C8—Etoposide—uterine cancer	0.028	0.0485	CbGbCtD
Perphenazine—CYP3A4—Progesterone—uterine cancer	0.0253	0.044	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—uterine cancer	0.0252	0.0437	CbGbCtD
Perphenazine—CYP1A2—Etoposide—uterine cancer	0.0217	0.0376	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—uterine cancer	0.0122	0.0211	CbGbCtD
Perphenazine—CYP3A4—Etoposide—uterine cancer	0.0113	0.0197	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—uterine cancer	0.00774	0.0134	CbGbCtD
Perphenazine—CALM2—semen—uterine cancer	0.00607	0.0493	CbGeAlD
Perphenazine—CALM1—semen—uterine cancer	0.00604	0.049	CbGeAlD
Perphenazine—CALM2—oviduct—uterine cancer	0.00445	0.0361	CbGeAlD
Perphenazine—CALM2—artery—uterine cancer	0.00295	0.0239	CbGeAlD
Perphenazine—CALM1—artery—uterine cancer	0.00293	0.0238	CbGeAlD
Perphenazine—HTR7—artery—uterine cancer	0.00287	0.0233	CbGeAlD
Perphenazine—CALM2—exocrine gland—uterine cancer	0.00257	0.0209	CbGeAlD
Perphenazine—CALM1—exocrine gland—uterine cancer	0.00256	0.0208	CbGeAlD
Perphenazine—CYP2C18—uterine cervix—uterine cancer	0.00248	0.0201	CbGeAlD
Perphenazine—CYP2C18—mammalian vulva—uterine cancer	0.00217	0.0176	CbGeAlD
Perphenazine—AOX1—myometrium—uterine cancer	0.00201	0.0163	CbGeAlD
Perphenazine—CALM3—myometrium—uterine cancer	0.00181	0.0147	CbGeAlD
Perphenazine—HTR2A—artery—uterine cancer	0.00179	0.0145	CbGeAlD
Perphenazine—CYP2C18—vagina—uterine cancer	0.00168	0.0136	CbGeAlD
Perphenazine—AOX1—uterine cervix—uterine cancer	0.00157	0.0127	CbGeAlD
Perphenazine—AOX1—decidua—uterine cancer	0.00149	0.0121	CbGeAlD
Perphenazine—AOX1—renal system—uterine cancer	0.00147	0.0119	CbGeAlD
Perphenazine—CALM2—myometrium—uterine cancer	0.00142	0.0116	CbGeAlD
Perphenazine—CALM1—myometrium—uterine cancer	0.00142	0.0115	CbGeAlD
Perphenazine—AOX1—endometrium—uterine cancer	0.00142	0.0115	CbGeAlD
Perphenazine—CALM3—uterine cervix—uterine cancer	0.00141	0.0115	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—uterine cancer	0.00137	0.0111	CbGeAlD
Perphenazine—AOX1—mammalian vulva—uterine cancer	0.00137	0.0111	CbGeAlD
Perphenazine—CALM3—decidua—uterine cancer	0.00134	0.0109	CbGeAlD
Perphenazine—AOX1—uterus—uterine cancer	0.00131	0.0106	CbGeAlD
Perphenazine—CALM3—endometrium—uterine cancer	0.00128	0.0104	CbGeAlD
Perphenazine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00709	CcSEcCtD
Perphenazine—CALM3—mammalian vulva—uterine cancer	0.00123	0.01	CbGeAlD
Perphenazine—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00676	CcSEcCtD
Perphenazine—CALM3—uterus—uterine cancer	0.00118	0.00955	CbGeAlD
Perphenazine—AOX1—female reproductive system—uterine cancer	0.00117	0.00953	CbGeAlD
Perphenazine—Dysphagia—Progesterone—uterine cancer	0.00117	0.0066	CcSEcCtD
Perphenazine—Asthma—Progesterone—uterine cancer	0.00117	0.0066	CcSEcCtD
Perphenazine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00658	CcSEcCtD
Perphenazine—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00651	CcSEcCtD
Perphenazine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00632	CcSEcCtD
Perphenazine—CALM2—epithelium—uterine cancer	0.00112	0.00907	CbGeAlD
Perphenazine—CALM1—epithelium—uterine cancer	0.00111	0.00903	CbGeAlD
Perphenazine—CALM2—uterine cervix—uterine cancer	0.00111	0.009	CbGeAlD
Perphenazine—CALM1—uterine cervix—uterine cancer	0.0011	0.00896	CbGeAlD
Perphenazine—HTR7—epithelium—uterine cancer	0.00109	0.00882	CbGeAlD
Perphenazine—Pain—Carboplatin—uterine cancer	0.00109	0.00611	CcSEcCtD
Perphenazine—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00611	CcSEcCtD
Perphenazine—CALM2—smooth muscle tissue—uterine cancer	0.00108	0.00874	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—uterine cancer	0.00107	0.0087	CbGeAlD
Perphenazine—AOX1—female gonad—uterine cancer	0.00107	0.00867	CbGeAlD
Perphenazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00598	CcSEcCtD
Perphenazine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00598	CcSEcCtD
Perphenazine—AOX1—vagina—uterine cancer	0.00106	0.00862	CbGeAlD
Perphenazine—Hyperglycaemia—Progesterone—uterine cancer	0.00106	0.00596	CcSEcCtD
Perphenazine—CALM2—decidua—uterine cancer	0.00106	0.00857	CbGeAlD
Perphenazine—HTR1A—renal system—uterine cancer	0.00106	0.00856	CbGeAlD
Perphenazine—CALM1—decidua—uterine cancer	0.00105	0.00853	CbGeAlD
Perphenazine—HTR7—smooth muscle tissue—uterine cancer	0.00105	0.0085	CbGeAlD
Perphenazine—Drowsiness—Progesterone—uterine cancer	0.00105	0.00589	CcSEcCtD
Perphenazine—CALM2—renal system—uterine cancer	0.00104	0.00842	CbGeAlD
Perphenazine—HRH1—myometrium—uterine cancer	0.00103	0.00839	CbGeAlD
Perphenazine—CALM1—renal system—uterine cancer	0.00103	0.00838	CbGeAlD
Perphenazine—Jaundice—Progesterone—uterine cancer	0.00102	0.00574	CcSEcCtD
Perphenazine—ADRA2A—myometrium—uterine cancer	0.00102	0.00825	CbGeAlD
Perphenazine—HTR7—renal system—uterine cancer	0.00101	0.00818	CbGeAlD
Perphenazine—HTR2C—female reproductive system—uterine cancer	0.001	0.00815	CbGeAlD
Perphenazine—Body temperature increased—Carboplatin—uterine cancer	0.001	0.00565	CcSEcCtD
Perphenazine—CALM2—endometrium—uterine cancer	0.001	0.00814	CbGeAlD
Perphenazine—CALM1—endometrium—uterine cancer	0.000998	0.0081	CbGeAlD
Perphenazine—Lethargy—Dactinomycin—uterine cancer	0.000979	0.00551	CcSEcCtD
Perphenazine—CALM2—mammalian vulva—uterine cancer	0.00097	0.00787	CbGeAlD
Perphenazine—CALM1—mammalian vulva—uterine cancer	0.000965	0.00784	CbGeAlD
Perphenazine—CALM3—female gonad—uterine cancer	0.000962	0.00781	CbGeAlD
Perphenazine—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000959	0.0054	CcSEcCtD
Perphenazine—CALM3—vagina—uterine cancer	0.000956	0.00776	CbGeAlD
Perphenazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000948	0.00533	CcSEcCtD
Perphenazine—Oedema peripheral—Progesterone—uterine cancer	0.000925	0.00521	CcSEcCtD
Perphenazine—CALM2—uterus—uterine cancer	0.000924	0.0075	CbGeAlD
Perphenazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000924	0.0052	CcSEcCtD
Perphenazine—CALM1—uterus—uterine cancer	0.00092	0.00746	CbGeAlD
Perphenazine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.000866	0.00488	CcSEcCtD
Perphenazine—CYP2C8—renal system—uterine cancer	0.000859	0.00698	CbGeAlD
Perphenazine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000838	0.00472	CcSEcCtD
Perphenazine—CYP2C8—endometrium—uterine cancer	0.000831	0.00674	CbGeAlD
Perphenazine—CALM2—female reproductive system—uterine cancer	0.000831	0.00674	CbGeAlD
Perphenazine—Dysphagia—Dactinomycin—uterine cancer	0.000829	0.00467	CcSEcCtD
Perphenazine—CALM1—female reproductive system—uterine cancer	0.000827	0.00671	CbGeAlD
Perphenazine—Erythema—Progesterone—uterine cancer	0.000817	0.0046	CcSEcCtD
Perphenazine—HRH1—epithelium—uterine cancer	0.000812	0.00659	CbGeAlD
Perphenazine—HTR7—female reproductive system—uterine cancer	0.000808	0.00655	CbGeAlD
Perphenazine—HRH1—uterine cervix—uterine cancer	0.000805	0.00653	CbGeAlD
Perphenazine—CYP1A2—renal system—uterine cancer	0.000804	0.00653	CbGeAlD
Perphenazine—ADRA2A—uterine cervix—uterine cancer	0.000791	0.00642	CbGeAlD
Perphenazine—Pancytopenia—Dactinomycin—uterine cancer	0.000787	0.00443	CcSEcCtD
Perphenazine—Muscle spasms—Progesterone—uterine cancer	0.000786	0.00442	CcSEcCtD
Perphenazine—HRH1—smooth muscle tissue—uterine cancer	0.000782	0.00635	CbGeAlD
Perphenazine—CYP2B6—renal system—uterine cancer	0.000771	0.00626	CbGeAlD
Perphenazine—Vision blurred—Progesterone—uterine cancer	0.00077	0.00434	CcSEcCtD
Perphenazine—HRH1—decidua—uterine cancer	0.000767	0.00622	CbGeAlD
Perphenazine—CALM2—female gonad—uterine cancer	0.000756	0.00613	CbGeAlD
Perphenazine—ADRA2A—decidua—uterine cancer	0.000753	0.00611	CbGeAlD
Perphenazine—CALM1—female gonad—uterine cancer	0.000752	0.00611	CbGeAlD
Perphenazine—CALM2—vagina—uterine cancer	0.000751	0.0061	CbGeAlD
Perphenazine—CALM1—vagina—uterine cancer	0.000748	0.00607	CbGeAlD
Perphenazine—Angioedema—Progesterone—uterine cancer	0.000747	0.0042	CcSEcCtD
Perphenazine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000741	0.00417	CcSEcCtD
Perphenazine—Syncope—Progesterone—uterine cancer	0.000733	0.00413	CcSEcCtD
Perphenazine—HRH1—endometrium—uterine cancer	0.000728	0.00591	CbGeAlD
Perphenazine—Loss of consciousness—Progesterone—uterine cancer	0.000718	0.00404	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Etoposide—uterine cancer	0.000717	0.00404	CcSEcCtD
Perphenazine—ADRA2A—endometrium—uterine cancer	0.000715	0.0058	CbGeAlD
Perphenazine—Cough—Progesterone—uterine cancer	0.000713	0.00401	CcSEcCtD
Perphenazine—CYP2C19—vagina—uterine cancer	0.000713	0.00579	CbGeAlD
Perphenazine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000712	0.00401	CcSEcCtD
Perphenazine—Convulsion—Progesterone—uterine cancer	0.000708	0.00399	CcSEcCtD
Perphenazine—Hypertension—Progesterone—uterine cancer	0.000706	0.00397	CcSEcCtD
Perphenazine—HRH1—mammalian vulva—uterine cancer	0.000704	0.00572	CbGeAlD
Perphenazine—ADRA2A—mammalian vulva—uterine cancer	0.000692	0.00561	CbGeAlD
Perphenazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00069	0.00388	CcSEcCtD
Perphenazine—CYP2C8—female reproductive system—uterine cancer	0.000688	0.00559	CbGeAlD
Perphenazine—AOX1—lymph node—uterine cancer	0.000687	0.00558	CbGeAlD
Perphenazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000681	0.00383	CcSEcCtD
Perphenazine—Dry mouth—Progesterone—uterine cancer	0.000681	0.00383	CcSEcCtD
Perphenazine—HTR2A—epithelium—uterine cancer	0.000678	0.0055	CbGeAlD
Perphenazine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00381	CcSEcCtD
Perphenazine—Confusional state—Progesterone—uterine cancer	0.000673	0.00379	CcSEcCtD
Perphenazine—Anaphylactic shock—Progesterone—uterine cancer	0.000667	0.00375	CcSEcCtD
Perphenazine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.00374	CcSEcCtD
Perphenazine—Infection—Progesterone—uterine cancer	0.000663	0.00373	CcSEcCtD
Perphenazine—Glycosuria—Epirubicin—uterine cancer	0.000662	0.00373	CcSEcCtD
Perphenazine—Cardiac arrest—Etoposide—uterine cancer	0.00066	0.00372	CcSEcCtD
Perphenazine—ADRA2A—uterus—uterine cancer	0.000659	0.00535	CbGeAlD
Perphenazine—Shock—Progesterone—uterine cancer	0.000656	0.00369	CcSEcCtD
Perphenazine—HTR2A—smooth muscle tissue—uterine cancer	0.000653	0.0053	CbGeAlD
Perphenazine—Tachycardia—Progesterone—uterine cancer	0.000651	0.00366	CcSEcCtD
Perphenazine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000651	0.00366	CcSEcCtD
Perphenazine—Blood disorder—Epirubicin—uterine cancer	0.000642	0.00361	CcSEcCtD
Perphenazine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.00361	CcSEcCtD
Perphenazine—Liver injury—Epirubicin—uterine cancer	0.000637	0.00359	CcSEcCtD
Perphenazine—Anorexia—Progesterone—uterine cancer	0.000636	0.00358	CcSEcCtD
Perphenazine—HTR2A—renal system—uterine cancer	0.000629	0.0051	CbGeAlD
Perphenazine—Hypotension—Progesterone—uterine cancer	0.000623	0.00351	CcSEcCtD
Perphenazine—CYP2C8—vagina—uterine cancer	0.000623	0.00505	CbGeAlD
Perphenazine—CALM3—lymph node—uterine cancer	0.000619	0.00502	CbGeAlD
Perphenazine—CYP2B6—female reproductive system—uterine cancer	0.000617	0.00501	CbGeAlD
Perphenazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000617	0.00347	CcSEcCtD
Perphenazine—Glycosuria—Doxorubicin—uterine cancer	0.000612	0.00345	CcSEcCtD
Perphenazine—CYP2C9—female reproductive system—uterine cancer	0.000611	0.00496	CbGeAlD
Perphenazine—Jaundice cholestatic—Epirubicin—uterine cancer	0.00061	0.00343	CcSEcCtD
Perphenazine—Amenorrhoea—Epirubicin—uterine cancer	0.00061	0.00343	CcSEcCtD
Perphenazine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00061	0.00343	CcSEcCtD
Perphenazine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000604	0.0034	CcSEcCtD
Perphenazine—Insomnia—Progesterone—uterine cancer	0.000603	0.0034	CcSEcCtD
Perphenazine—HRH1—female reproductive system—uterine cancer	0.000603	0.00489	CbGeAlD
Perphenazine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000601	0.00338	CcSEcCtD
Perphenazine—Dysphagia—Etoposide—uterine cancer	0.0006	0.00338	CcSEcCtD
Perphenazine—Dyspnoea—Progesterone—uterine cancer	0.000595	0.00335	CcSEcCtD
Perphenazine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000595	0.00335	CcSEcCtD
Perphenazine—Blood disorder—Doxorubicin—uterine cancer	0.000594	0.00334	CcSEcCtD
Perphenazine—Somnolence—Progesterone—uterine cancer	0.000593	0.00334	CcSEcCtD
Perphenazine—ADRA2A—female reproductive system—uterine cancer	0.000592	0.00481	CbGeAlD
Perphenazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00059	0.00332	CcSEcCtD
Perphenazine—Liver injury—Doxorubicin—uterine cancer	0.00059	0.00332	CcSEcCtD
Perphenazine—CYP3A4—renal system—uterine cancer	0.000582	0.00473	CbGeAlD
Perphenazine—Decreased appetite—Progesterone—uterine cancer	0.00058	0.00326	CcSEcCtD
Perphenazine—Erythema—Dactinomycin—uterine cancer	0.000578	0.00325	CcSEcCtD
Perphenazine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000576	0.00324	CcSEcCtD
Perphenazine—CYP2D6—renal system—uterine cancer	0.000573	0.00465	CbGeAlD
Perphenazine—Dyskinesia—Epirubicin—uterine cancer	0.000571	0.00321	CcSEcCtD
Perphenazine—Pain—Progesterone—uterine cancer	0.00057	0.00321	CcSEcCtD
Perphenazine—Constipation—Progesterone—uterine cancer	0.00057	0.00321	CcSEcCtD
Perphenazine—Pancytopenia—Etoposide—uterine cancer	0.00057	0.00321	CcSEcCtD
Perphenazine—Dysarthria—Epirubicin—uterine cancer	0.000567	0.00319	CcSEcCtD
Perphenazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000565	0.00318	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—uterine cancer	0.000565	0.00318	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000565	0.00318	CcSEcCtD
Perphenazine—CYP2B6—vagina—uterine cancer	0.000558	0.00453	CbGeAlD
Perphenazine—HRH1—female gonad—uterine cancer	0.000549	0.00445	CbGeAlD
Perphenazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000547	0.00308	CcSEcCtD
Perphenazine—HRH1—vagina—uterine cancer	0.000545	0.00443	CbGeAlD
Perphenazine—ADRA2A—female gonad—uterine cancer	0.000539	0.00437	CbGeAlD
Perphenazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000539	0.00303	CcSEcCtD
Perphenazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000537	0.00302	CcSEcCtD
Perphenazine—Hepatocellular injury—Epirubicin—uterine cancer	0.000536	0.00302	CcSEcCtD
Perphenazine—ADRA2A—vagina—uterine cancer	0.000536	0.00435	CbGeAlD
Perphenazine—Urticaria—Progesterone—uterine cancer	0.00053	0.00298	CcSEcCtD
Perphenazine—Dermatitis contact—Epirubicin—uterine cancer	0.00053	0.00298	CcSEcCtD
Perphenazine—Abnormal dreams—Epirubicin—uterine cancer	0.00053	0.00298	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—uterine cancer	0.000528	0.00297	CcSEcCtD
Perphenazine—Body temperature increased—Progesterone—uterine cancer	0.000527	0.00297	CcSEcCtD
Perphenazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000525	0.00296	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—uterine cancer	0.000524	0.00295	CcSEcCtD
Perphenazine—Jaundice—Etoposide—uterine cancer	0.000522	0.00294	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—uterine cancer	0.000521	0.00293	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—uterine cancer	0.000517	0.00291	CcSEcCtD
Perphenazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000517	0.00291	CcSEcCtD
Perphenazine—HTR2A—female reproductive system—uterine cancer	0.000504	0.00409	CbGeAlD
Perphenazine—Agranulocytosis—Etoposide—uterine cancer	0.000499	0.00281	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—uterine cancer	0.000496	0.00279	CcSEcCtD
Perphenazine—Hypersensitivity—Progesterone—uterine cancer	0.000491	0.00277	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—uterine cancer	0.00049	0.00276	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—uterine cancer	0.00049	0.00276	CcSEcCtD
Perphenazine—CALM2—lymph node—uterine cancer	0.000486	0.00394	CbGeAlD
Perphenazine—CALM1—lymph node—uterine cancer	0.000484	0.00393	CbGeAlD
Perphenazine—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000482	0.00271	CcSEcCtD
Perphenazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00048	0.0027	CcSEcCtD
Perphenazine—Hypoaesthesia—Etoposide—uterine cancer	0.000478	0.00269	CcSEcCtD
Perphenazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000478	0.00269	CcSEcCtD
Perphenazine—Pruritus—Progesterone—uterine cancer	0.000472	0.00266	CcSEcCtD
Perphenazine—Infection—Dactinomycin—uterine cancer	0.000468	0.00264	CcSEcCtD
Perphenazine—CYP3A4—female reproductive system—uterine cancer	0.000466	0.00378	CbGeAlD
Perphenazine—CYP2D6—female reproductive system—uterine cancer	0.000459	0.00372	CbGeAlD
Perphenazine—Diarrhoea—Progesterone—uterine cancer	0.000456	0.00257	CcSEcCtD
Perphenazine—HTR2A—vagina—uterine cancer	0.000455	0.0037	CbGeAlD
Perphenazine—Anorexia—Dactinomycin—uterine cancer	0.000449	0.00253	CcSEcCtD
Perphenazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000445	0.00251	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—uterine cancer	0.000443	0.00249	CcSEcCtD
Perphenazine—Dizziness—Progesterone—uterine cancer	0.000441	0.00248	CcSEcCtD
Perphenazine—Eczema—Epirubicin—uterine cancer	0.000433	0.00244	CcSEcCtD
Perphenazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000428	0.00241	CcSEcCtD
Perphenazine—Headache—Progesterone—uterine cancer	0.000418	0.00235	CcSEcCtD
Perphenazine—CYP2D6—female gonad—uterine cancer	0.000417	0.00339	CbGeAlD
Perphenazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000414	0.00233	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000412	0.00232	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—uterine cancer	0.00041	0.00231	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—uterine cancer	0.00041	0.00231	CcSEcCtD
Perphenazine—Pain—Dactinomycin—uterine cancer	0.000403	0.00227	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000402	0.00226	CcSEcCtD
Perphenazine—Muscle spasms—Etoposide—uterine cancer	0.000402	0.00226	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—uterine cancer	0.000401	0.00226	CcSEcCtD
Perphenazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0004	0.00225	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—uterine cancer	0.000399	0.00224	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—uterine cancer	0.000397	0.00224	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000382	0.00215	CcSEcCtD
Perphenazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00213	CcSEcCtD
Perphenazine—Leukopenia—Etoposide—uterine cancer	0.000374	0.00211	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—uterine cancer	0.000373	0.0021	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000372	0.00209	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—uterine cancer	0.00037	0.00208	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000369	0.00208	CcSEcCtD
Perphenazine—Loss of consciousness—Etoposide—uterine cancer	0.000367	0.00207	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—uterine cancer	0.000367	0.00207	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—uterine cancer	0.000366	0.00206	CcSEcCtD
Perphenazine—Cough—Etoposide—uterine cancer	0.000365	0.00205	CcSEcCtD
Perphenazine—Convulsion—Etoposide—uterine cancer	0.000362	0.00204	CcSEcCtD
Perphenazine—Hypertension—Etoposide—uterine cancer	0.000361	0.00203	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000355	0.002	CcSEcCtD
Perphenazine—HRH1—lymph node—uterine cancer	0.000353	0.00286	CbGeAlD
Perphenazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000347	0.00196	CcSEcCtD
Perphenazine—ADRA2A—lymph node—uterine cancer	0.000346	0.00281	CbGeAlD
Perphenazine—Confusional state—Etoposide—uterine cancer	0.000344	0.00194	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—uterine cancer	0.000343	0.00193	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—uterine cancer	0.000342	0.00193	CcSEcCtD
Perphenazine—Anaphylactic shock—Etoposide—uterine cancer	0.000341	0.00192	CcSEcCtD
Perphenazine—Infection—Etoposide—uterine cancer	0.000339	0.00191	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—uterine cancer	0.000339	0.00191	CcSEcCtD
Perphenazine—Asthma—Epirubicin—uterine cancer	0.000336	0.00189	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—uterine cancer	0.000336	0.00189	CcSEcCtD
Perphenazine—Tachycardia—Etoposide—uterine cancer	0.000333	0.00187	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—uterine cancer	0.000333	0.00187	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000329	0.00185	CcSEcCtD
Perphenazine—Anorexia—Etoposide—uterine cancer	0.000325	0.00183	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—uterine cancer	0.000323	0.00182	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—uterine cancer	0.000319	0.0018	CcSEcCtD
Perphenazine—Hypotension—Etoposide—uterine cancer	0.000319	0.00179	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—uterine cancer	0.000318	0.00179	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—uterine cancer	0.000311	0.00175	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—uterine cancer	0.000311	0.00175	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—uterine cancer	0.000308	0.00173	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000307	0.00173	CcSEcCtD
Perphenazine—Dyspnoea—Etoposide—uterine cancer	0.000304	0.00171	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—uterine cancer	0.000303	0.00171	CcSEcCtD
Perphenazine—Somnolence—Etoposide—uterine cancer	0.000303	0.00171	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—uterine cancer	0.0003	0.00169	CcSEcCtD
Perphenazine—Decreased appetite—Etoposide—uterine cancer	0.000297	0.00167	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—uterine cancer	0.000296	0.00166	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—uterine cancer	0.000292	0.00165	CcSEcCtD
Perphenazine—Pain—Etoposide—uterine cancer	0.000292	0.00164	CcSEcCtD
Perphenazine—Constipation—Etoposide—uterine cancer	0.000292	0.00164	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000284	0.0016	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000281	0.00158	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—uterine cancer	0.00028	0.00158	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—uterine cancer	0.000278	0.00156	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—uterine cancer	0.000274	0.00154	CcSEcCtD
Perphenazine—Urticaria—Etoposide—uterine cancer	0.000271	0.00153	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—uterine cancer	0.000271	0.00152	CcSEcCtD
Perphenazine—Body temperature increased—Etoposide—uterine cancer	0.00027	0.00152	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—uterine cancer	0.000268	0.00151	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—uterine cancer	0.000265	0.00149	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000259	0.00146	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—uterine cancer	0.000254	0.00143	CcSEcCtD
Perphenazine—Hypersensitivity—Etoposide—uterine cancer	0.000251	0.00142	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000248	0.0014	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—uterine cancer	0.000245	0.00138	CcSEcCtD
Perphenazine—Pruritus—Etoposide—uterine cancer	0.000241	0.00136	CcSEcCtD
Perphenazine—Erythema—Epirubicin—uterine cancer	0.000234	0.00132	CcSEcCtD
Perphenazine—Diarrhoea—Etoposide—uterine cancer	0.000233	0.00131	CcSEcCtD
Perphenazine—Dizziness—Etoposide—uterine cancer	0.000226	0.00127	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—uterine cancer	0.000225	0.00127	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—uterine cancer	0.000221	0.00124	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—uterine cancer	0.000217	0.00122	CcSEcCtD
Perphenazine—Agitation—Epirubicin—uterine cancer	0.000215	0.00121	CcSEcCtD
Perphenazine—Headache—Etoposide—uterine cancer	0.000214	0.0012	CcSEcCtD
Perphenazine—Syncope—Epirubicin—uterine cancer	0.00021	0.00118	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—uterine cancer	0.00021	0.00118	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—uterine cancer	0.000209	0.00117	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—uterine cancer	0.000206	0.00116	CcSEcCtD
Perphenazine—Cough—Epirubicin—uterine cancer	0.000205	0.00115	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—uterine cancer	0.000204	0.00115	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—uterine cancer	0.000203	0.00114	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—uterine cancer	0.000202	0.00114	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—uterine cancer	0.000199	0.00112	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—uterine cancer	0.000195	0.0011	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—uterine cancer	0.000194	0.00109	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—uterine cancer	0.000194	0.00109	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—uterine cancer	0.000193	0.00109	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—uterine cancer	0.000191	0.00108	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—uterine cancer	0.000191	0.00107	CcSEcCtD
Perphenazine—Infection—Epirubicin—uterine cancer	0.00019	0.00107	CcSEcCtD
Perphenazine—Cough—Doxorubicin—uterine cancer	0.000189	0.00107	CcSEcCtD
Perphenazine—Shock—Epirubicin—uterine cancer	0.000188	0.00106	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—uterine cancer	0.000188	0.00106	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—uterine cancer	0.000187	0.00105	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—uterine cancer	0.000187	0.00105	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—uterine cancer	0.000182	0.00103	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—uterine cancer	0.000181	0.00102	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—uterine cancer	0.000179	0.00101	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—uterine cancer	0.000178	0.001	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000177	0.000996	CcSEcCtD
Perphenazine—Infection—Doxorubicin—uterine cancer	0.000176	0.00099	CcSEcCtD
Perphenazine—Shock—Doxorubicin—uterine cancer	0.000174	0.00098	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—uterine cancer	0.000173	0.000974	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—uterine cancer	0.000173	0.000972	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—uterine cancer	0.000171	0.00096	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—uterine cancer	0.00017	0.000957	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—uterine cancer	0.000169	0.00095	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—uterine cancer	0.000166	0.000936	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—uterine cancer	0.000165	0.000931	CcSEcCtD
Perphenazine—Pain—Epirubicin—uterine cancer	0.000164	0.000921	CcSEcCtD
Perphenazine—Constipation—Epirubicin—uterine cancer	0.000164	0.000921	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—uterine cancer	0.00016	0.000901	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—uterine cancer	0.000158	0.000888	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—uterine cancer	0.000157	0.000886	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—uterine cancer	0.000154	0.000866	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—uterine cancer	0.000152	0.000855	CcSEcCtD
Perphenazine—Pain—Doxorubicin—uterine cancer	0.000151	0.000852	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—uterine cancer	0.000151	0.000852	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—uterine cancer	0.000151	0.000851	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—uterine cancer	0.000141	0.000793	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—uterine cancer	0.000141	0.000791	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—uterine cancer	0.00014	0.000788	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—uterine cancer	0.000135	0.000762	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—uterine cancer	0.000131	0.000737	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—uterine cancer	0.00013	0.000734	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—uterine cancer	0.000126	0.000712	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—uterine cancer	0.000125	0.000705	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—uterine cancer	0.000121	0.000682	CcSEcCtD
Perphenazine—Headache—Epirubicin—uterine cancer	0.00012	0.000675	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—uterine cancer	0.000117	0.000659	CcSEcCtD
Perphenazine—Headache—Doxorubicin—uterine cancer	0.000111	0.000624	CcSEcCtD
Perphenazine—CYP2C18—Metabolism—AKT1—uterine cancer	8.62e-06	7.03e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	8.61e-06	7.03e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ERBB2—uterine cancer	8.59e-06	7.01e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	8.59e-06	7.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	8.56e-06	6.99e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTEN—uterine cancer	8.55e-06	6.97e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EP300—uterine cancer	8.54e-06	6.97e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EP300—uterine cancer	8.54e-06	6.97e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	8.52e-06	6.96e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	8.52e-06	6.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—AKT1—uterine cancer	8.51e-06	6.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—AKT1—uterine cancer	8.51e-06	6.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CTNNB1—uterine cancer	8.48e-06	6.92e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CTNNB1—uterine cancer	8.48e-06	6.92e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	8.45e-06	6.9e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ERBB2—uterine cancer	8.44e-06	6.88e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL2—uterine cancer	8.42e-06	6.87e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTEN—uterine cancer	8.34e-06	6.81e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTEN—uterine cancer	8.3e-06	6.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTEN—uterine cancer	8.27e-06	6.75e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTEN—uterine cancer	8.27e-06	6.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NRAS—uterine cancer	8.26e-06	6.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EP300—uterine cancer	8.15e-06	6.65e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL8—uterine cancer	8.15e-06	6.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—uterine cancer	8.14e-06	6.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—uterine cancer	8.14e-06	6.64e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—uterine cancer	8.14e-06	6.64e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	8.1e-06	6.61e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—HRAS—uterine cancer	8.09e-06	6.61e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.03e-06	6.55e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	8.02e-06	6.54e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL8—uterine cancer	8e-06	6.53e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—STK11—uterine cancer	7.99e-06	6.52e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.99e-06	6.52e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NRAS—uterine cancer	7.99e-06	6.52e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NRAS—uterine cancer	7.99e-06	6.52e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	7.96e-06	6.5e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EP300—uterine cancer	7.96e-06	6.49e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	7.96e-06	6.49e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PIK3CA—uterine cancer	7.95e-06	6.49e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—HRAS—uterine cancer	7.95e-06	6.49e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PIK3CA—uterine cancer	7.94e-06	6.48e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EP300—uterine cancer	7.92e-06	6.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EP300—uterine cancer	7.88e-06	6.43e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EP300—uterine cancer	7.88e-06	6.43e-05	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	7.87e-06	6.42e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTEN—uterine cancer	7.84e-06	6.4e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	7.83e-06	6.39e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	7.83e-06	6.39e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	7.81e-06	6.37e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MTHFR—uterine cancer	7.78e-06	6.35e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—KRAS—uterine cancer	7.78e-06	6.35e-05	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	7.74e-06	6.32e-05	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	7.73e-06	6.31e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—uterine cancer	7.69e-06	6.28e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	7.69e-06	6.28e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—uterine cancer	7.68e-06	6.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—NRAS—uterine cancer	7.62e-06	6.22e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—uterine cancer	7.54e-06	6.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—uterine cancer	7.52e-06	6.14e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—uterine cancer	7.52e-06	6.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	7.52e-06	6.13e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	7.5e-06	6.12e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—EP300—uterine cancer	7.48e-06	6.1e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—uterine cancer	7.45e-06	6.08e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NRAS—uterine cancer	7.44e-06	6.07e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NRAS—uterine cancer	7.41e-06	6.04e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	7.4e-06	6.04e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	7.38e-06	6.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—uterine cancer	7.37e-06	6.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—uterine cancer	7.37e-06	6.02e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—uterine cancer	7.36e-06	6e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTEN—uterine cancer	7.35e-06	6e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—uterine cancer	7.35e-06	6e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTEN—uterine cancer	7.33e-06	5.98e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	7.29e-06	5.95e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	7.25e-06	5.91e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTEN—uterine cancer	7.21e-06	5.88e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTEN—uterine cancer	7.19e-06	5.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTEN—uterine cancer	7.16e-06	5.84e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	7.15e-06	5.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	7.15e-06	5.83e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	7.12e-06	5.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—uterine cancer	7.11e-06	5.8e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	7.03e-06	5.74e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—uterine cancer	7.02e-06	5.73e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ERBB2—uterine cancer	7.02e-06	5.73e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—EP300—uterine cancer	7.01e-06	5.72e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EP300—uterine cancer	6.99e-06	5.7e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTEN—uterine cancer	6.92e-06	5.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTEN—uterine cancer	6.92e-06	5.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	6.91e-06	5.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	6.91e-06	5.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—uterine cancer	6.87e-06	5.61e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—uterine cancer	6.87e-06	5.61e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EP300—uterine cancer	6.87e-06	5.61e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EP300—uterine cancer	6.86e-06	5.6e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.86e-06	5.6e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—uterine cancer	6.85e-06	5.59e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—EP300—uterine cancer	6.82e-06	5.57e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—uterine cancer	6.79e-06	5.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—uterine cancer	6.79e-06	5.54e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	6.73e-06	5.49e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—uterine cancer	6.65e-06	5.43e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—uterine cancer	6.62e-06	5.4e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	6.62e-06	5.4e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—uterine cancer	6.61e-06	5.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—EP300—uterine cancer	6.6e-06	5.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—EP300—uterine cancer	6.6e-06	5.39e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—uterine cancer	6.56e-06	5.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	6.56e-06	5.35e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—uterine cancer	6.54e-06	5.33e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—uterine cancer	6.53e-06	5.33e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	6.51e-06	5.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—uterine cancer	6.5e-06	5.3e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—uterine cancer	6.5e-06	5.3e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—uterine cancer	6.5e-06	5.3e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—uterine cancer	6.49e-06	5.3e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—uterine cancer	6.44e-06	5.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—uterine cancer	6.44e-06	5.25e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—uterine cancer	6.43e-06	5.25e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—uterine cancer	6.42e-06	5.24e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—uterine cancer	6.41e-06	5.23e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	6.4e-06	5.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—uterine cancer	6.4e-06	5.22e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—uterine cancer	6.4e-06	5.22e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—uterine cancer	6.37e-06	5.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—uterine cancer	6.35e-06	5.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—uterine cancer	6.35e-06	5.18e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—uterine cancer	6.33e-06	5.17e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—uterine cancer	6.32e-06	5.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—uterine cancer	6.32e-06	5.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—uterine cancer	6.29e-06	5.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—uterine cancer	6.29e-06	5.13e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EP300—uterine cancer	6.25e-06	5.1e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—uterine cancer	6.23e-06	5.08e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—uterine cancer	6.14e-06	5.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—uterine cancer	6.04e-06	4.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—uterine cancer	6.03e-06	4.92e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—uterine cancer	6.01e-06	4.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—uterine cancer	5.98e-06	4.88e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—uterine cancer	5.94e-06	4.85e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—uterine cancer	5.94e-06	4.85e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—EP300—uterine cancer	5.94e-06	4.84e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	5.92e-06	4.83e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	5.89e-06	4.8e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	5.86e-06	4.78e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	5.85e-06	4.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—uterine cancer	5.84e-06	4.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—uterine cancer	5.84e-06	4.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—uterine cancer	5.84e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—uterine cancer	5.83e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—uterine cancer	5.83e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—uterine cancer	5.79e-06	4.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—uterine cancer	5.79e-06	4.72e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EP300—uterine cancer	5.71e-06	4.66e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—uterine cancer	5.69e-06	4.65e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—uterine cancer	5.67e-06	4.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—uterine cancer	5.65e-06	4.61e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—uterine cancer	5.65e-06	4.61e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—uterine cancer	5.63e-06	4.59e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—uterine cancer	5.59e-06	4.56e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—uterine cancer	5.58e-06	4.55e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—uterine cancer	5.56e-06	4.53e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—uterine cancer	5.54e-06	4.52e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—uterine cancer	5.53e-06	4.52e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—uterine cancer	5.52e-06	4.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EP300—uterine cancer	5.52e-06	4.5e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EP300—uterine cancer	5.52e-06	4.5e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—uterine cancer	5.45e-06	4.44e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—uterine cancer	5.42e-06	4.42e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—uterine cancer	5.4e-06	4.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—uterine cancer	5.4e-06	4.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—uterine cancer	5.4e-06	4.4e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—uterine cancer	5.34e-06	4.36e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—uterine cancer	5.33e-06	4.35e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—EP300—uterine cancer	5.3e-06	4.32e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—uterine cancer	5.23e-06	4.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—uterine cancer	5.23e-06	4.27e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—uterine cancer	5.19e-06	4.23e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	5.17e-06	4.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—uterine cancer	5.16e-06	4.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—uterine cancer	5.16e-06	4.21e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—uterine cancer	5.16e-06	4.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—uterine cancer	5.16e-06	4.21e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—uterine cancer	5.11e-06	4.17e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	5.09e-06	4.15e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	5.07e-06	4.14e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—uterine cancer	5.07e-06	4.13e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—uterine cancer	5.05e-06	4.12e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	5.04e-06	4.11e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—uterine cancer	5e-06	4.08e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—uterine cancer	4.92e-06	4.02e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—uterine cancer	4.92e-06	4.01e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—uterine cancer	4.91e-06	4.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—uterine cancer	4.88e-06	3.99e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—uterine cancer	4.88e-06	3.99e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—EP300—uterine cancer	4.87e-06	3.98e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—EP300—uterine cancer	4.83e-06	3.94e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—uterine cancer	4.81e-06	3.92e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—uterine cancer	4.78e-06	3.9e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—uterine cancer	4.78e-06	3.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—uterine cancer	4.76e-06	3.89e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—uterine cancer	4.76e-06	3.89e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—uterine cancer	4.7e-06	3.84e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—uterine cancer	4.69e-06	3.83e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	4.63e-06	3.78e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—uterine cancer	4.59e-06	3.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—uterine cancer	4.52e-06	3.69e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—uterine cancer	4.48e-06	3.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—uterine cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—uterine cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—uterine cancer	4.39e-06	3.58e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—uterine cancer	4.33e-06	3.53e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	4.28e-06	3.49e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—uterine cancer	4.24e-06	3.46e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—uterine cancer	4.22e-06	3.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—uterine cancer	4.22e-06	3.44e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—uterine cancer	4.15e-06	3.39e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—uterine cancer	4.15e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—EP300—uterine cancer	4.13e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—uterine cancer	4.12e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—uterine cancer	4.08e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—uterine cancer	4.08e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—uterine cancer	4.08e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—uterine cancer	3.99e-06	3.26e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—uterine cancer	3.99e-06	3.26e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—uterine cancer	3.95e-06	3.22e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—uterine cancer	3.95e-06	3.22e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.92e-06	3.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—uterine cancer	3.91e-06	3.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	3.78e-06	3.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—uterine cancer	3.78e-06	3.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—uterine cancer	3.78e-06	3.08e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	3.61e-06	2.94e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—uterine cancer	3.59e-06	2.93e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.57e-06	2.92e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—uterine cancer	3.45e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—uterine cancer	3.34e-06	2.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—uterine cancer	3.34e-06	2.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—uterine cancer	3.34e-06	2.72e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—uterine cancer	3.2e-06	2.61e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—EP300—uterine cancer	3.19e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.05e-06	2.49e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—uterine cancer	2.95e-06	2.4e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—uterine cancer	2.92e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—uterine cancer	2.5e-06	2.04e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.36e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—uterine cancer	1.93e-06	1.57e-05	CbGpPWpGaD
